Dr. Reddy's Laboratories launches Amlodipine Besylate and Atorvastatin Calcium Tablets

Published on March 27, 2014 at 5:13 AM · No Comments

Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10mg, 2.5/20mg, 2.5/40mg, 5/10mg, 5/20mg, 5/40mg, 5/80mg, 10/10mg, 10/20mg, 10/40mg and 10/80 mg a therapeutic equivalent generic version of CADUET® (amlodipine Besylate and atorvastatin calcium) tablets, in the US market on March 26, 2014, following the approval by the United States Food & Drug Administration (USFDA).

The CADUET® tablets brand and generic had U.S. sales of approximately $163 Million MAT for the most recent twelve months ending in January 2014 according to IMS Health*.

Dr. Reddy's Amlodipine Besylate and Atorvastatin Calcium Tablets are available in bottle counts of 30 and 90**.


Dr. Reddy's Laboratories Ltd.

Posted in: Pharmaceutical News

Tags: , , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
Study shows new role of zinc in optic nerve injury